Cargando…
SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes
Drug markets revisits herbal medicines, as historical usages address their therapeutic efficacies with less adverse effects. Moreover, herbal medicines save both cost and time in development. SH003, a modified version of traditional herbal medicine extracted from Astragalus membranaceus (Am), Angeli...
Autores principales: | Choi, Youn Kyung, Cho, Sung-Gook, Choi, Yu-Jeong, Yun, Yee Jin, Lee, Kang Min, Lee, Kangwook, Yoo, Hye-Hyun, Shin, Yong Cheol, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687613/ https://www.ncbi.nlm.nih.gov/pubmed/29179443 http://dx.doi.org/10.18632/oncotarget.11393 |
Ejemplares similares
-
SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016) -
Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel
por: Choi, Yu-Jeong, et al.
Publicado: (2022) -
State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent
por: Lee, Kangwook, et al.
Publicado: (2022) -
SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022) -
Herbal Extract SH003 Suppresses Tumor Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Inhibiting STAT3-IL-6 Signaling
por: Choi, Youn Kyung, et al.
Publicado: (2014)